Literature DB >> 34616035

Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms.

Mylène P Jansen1, Simon C Mastbergen2.   

Abstract

Joint distraction, the prolonged mechanical separation of the bones at a joint, has emerged as a joint-preserving treatment for end-stage osteoarthritis, with the gradually growing promise of implementation in regular clinical practice. Joint distraction of the knee has been most extensively studied, with these studies showing prolonged symptomatic improvement in combination with repair of cartilage tissue in degenerated knee joints, supporting the concept that cartilage repair can translate into real clinical benefit. The reversal of tissue degeneration observed with joint distraction could be the result of one or a combination of various proposed mechanisms, including partial unloading, synovial fluid pressure oscillation, mechanical and biochemical changes in subchondral bone, adhesion and chondrogenic commitment of joint-derived mesenchymal stem cells or a change in the molecular milieu of the joint. The overall picture that emerges from the combined evidence is relevant for future research and treatment-related improvements of joint distraction and for translation of the insights gained about tissue repair to other joint-preserving techniques. It remains to be elucidated whether optimizing the biomechanical conditions during joint distraction can actually cure osteoarthritis rather than only providing temporary symptomatic relief, but even temporary relief might be relevant for society and patients, as it will delay joint replacement with a prosthesis at an early age and thereby avert revision surgery later in life. Most importantly, improved insights into the underlying mechanisms of joint repair might provide new leads for more targeted treatment options.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34616035     DOI: 10.1038/s41584-021-00695-y

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  78 in total

1.  A new articulated distraction arthroplasty device for treatment of the osteoarthritic knee joint: a preliminary report.

Authors:  Masataka Deie; Mitsuo Ochi; Nobuo Adachi; Ryoji Kajiwara; Atsushi Kanaya
Journal:  Arthroscopy       Date:  2007-08       Impact factor: 4.772

2.  Freiberg's infraction of the second metatarsal treated with autologous osteochondral transplantation and external fixation.

Authors:  J George DeVries; Robby A Amiot; Patrick Cummings; Nathan Sockrider
Journal:  J Foot Ankle Surg       Date:  2008-09-27       Impact factor: 1.286

Review 3.  Unloading joints to treat osteoarthritis, including joint distraction.

Authors:  Floris P J G Lafeber; Femke Intema; Peter M Van Roermund; Anne C A Marijnissen
Journal:  Curr Opin Rheumatol       Date:  2006-09       Impact factor: 5.006

Review 4.  Osteoarthritis.

Authors:  David J Hunter; Sita Bierma-Zeinstra
Journal:  Lancet       Date:  2019-04-27       Impact factor: 79.321

5.  Surgical interventions for symptomatic mild to moderate knee osteoarthritis.

Authors:  Jonathan S Palmer; A Paul Monk; Sally Hopewell; Lee E Bayliss; William Jackson; David J Beard; Andrew J Price
Journal:  Cochrane Database Syst Rev       Date:  2019-07-19

6.  Joint distraction in treatment of osteoarthritis: a two-year follow-up of the ankle.

Authors:  A A van Valburg; P M van Roermund; A C Marijnissen; J van Melkebeek; J Lammens; A J Verbout; F P Lafeber; J W Bijlsma
Journal:  Osteoarthritis Cartilage       Date:  1999-09       Impact factor: 6.576

7.  Joint distraction for thumb carpometacarpal osteoarthritis: a feasibility study with 1-year follow-up.

Authors:  Anne J Spaans; L Paul van Minnen; Assa Braakenburg; Aebele B Mink van der Molen
Journal:  J Plast Surg Hand Surg       Date:  2016-10-19

Review 8.  Functional articular cartilage repair: here, near, or is the best approach not yet clear?

Authors:  Simon C Mastbergen; Daniël B F Saris; Floris P J G Lafeber
Journal:  Nat Rev Rheumatol       Date:  2013-03-19       Impact factor: 20.543

9.  Letter to the Editor.

Authors:  Mylène Jansen; Floris Lafeber
Journal:  Cartilage       Date:  2020-10-26       Impact factor: 4.634

10.  Knee joint distraction in regular care for treatment of knee osteoarthritis: A comparison with clinical trial data.

Authors:  Mylène P Jansen; Simon C Mastbergen; Ronald J van Heerwaarden; Sander Spruijt; Michelle D van Empelen; Esmee C Kester; Floris P J G Lafeber; Roel J H Custers
Journal:  PLoS One       Date:  2020-01-22       Impact factor: 3.240

View more
  5 in total

1.  Patients with advanced lateral osteoarthritis can return to sports and work after distraction arthroplasty plus lateral meniscal allograft transplantation combined with cartilage repair.

Authors:  Dhong Won Lee; Dong Ryun Lee; Min Ah Kim; Seung Ik Cho; Joon Kyu Lee; Jin Goo Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-02-14       Impact factor: 4.342

Review 2.  Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms.

Authors:  Mylène P Jansen; Simon C Mastbergen
Journal:  Nat Rev Rheumatol       Date:  2021-10-06       Impact factor: 20.543

3.  Chondroitin sulfate-functionalized lipid nanoreservoirs: a novel cartilage-targeting approach for intra-articular delivery of cassic acid for osteoarthritis treatment.

Authors:  Heba M K Ebada; Maha M A Nasra; Rasha A Nassra; Ossama Y Abdallah
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

4.  Intermittent Hydrostatic Pressure Promotes Cartilage Repair in an Inflammatory Environment through Hippo-YAP Signaling In Vitro and In Vivo.

Authors:  Wangxiang Yao; An Ma; Zhen Zhang; Liulong Zhu
Journal:  Biomed Res Int       Date:  2022-08-04       Impact factor: 3.246

Review 5.  Recent advances in enzyme-related biomaterials for arthritis treatment.

Authors:  Xin-Hao Liu; Jia-Ying Ding; Zhi-Heng Zhu; Xi-Chen Wu; Yong-Jia Song; Xiao-Ling Xu; Dao-Fang Ding
Journal:  Front Chem       Date:  2022-08-16       Impact factor: 5.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.